1、 阳艳丽,潘玉琴,何帮顺,等. 哮喘患儿外周血调节性T细胞和Th1/Th2的变化及其与哮喘病情的关系[J]. 中国当代儿科杂志,2011,6:482-486. 阳艳丽,潘玉琴,何帮顺,等. 哮喘患儿外周血调节性T细胞和Th1/Th2的变化及其与哮喘病情的关系[J]. 中国当代儿科杂志,2011,6:482-486.
2、 杨昭慧. 哮喘患儿应用孟鲁司特钠治疗的临床效果[J]. 中国医药指南, 2013, 31:94-95. 杨昭慧. 哮喘患儿应用孟鲁司特钠治疗的临床效果[J]. 中国医药指南, 2013, 31:94-95.
3、 HEENDERSON WR, TANG LO, CHU SJ, et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model[J]. Am J Respir Crit Care Med,2002,165(1):108-116. HEENDERSON WR, TANG LO, CHU SJ, et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model[J]. Am J Respir Crit Care Med,2002,165(1):108-116.
4、 EKALADZE E, PKHAKADZE I, ALAVIDZE N, et al. K.Role of Montelukast in treatment of mild and severe forms of asthma. Georgian Med News. 2014 Jul-Aug;(232-233):56-60. EKALADZE E, PKHAKADZE I, ALAVIDZE N, et al. K.Role of Montelukast in treatment of mild and severe forms of asthma. Georgian Med News. 2014 Jul-Aug;(232-233):56-60.
5、 阳永珍. 孟鲁司特钠口服加舒利迭吸入治疗重度哮喘的疗效观察[J]. 大家健康(学术版),2015,01:143-144. 阳永珍. 孟鲁司特钠口服加舒利迭吸入治疗重度哮喘的疗效观察[J]. 大家健康(学术版),2015,01:143-144.
6、 STELMACH I, OZAREK-HANC A, ZACZENIUK M, et al. Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: randomized, placebo controlled trial.Pulm Pharmacol Ther. 2015 Apr;31:42-8. doi: 10.1016/j.pupt.2015.01.004. Epub 2015 Jan 30. STELMACH I, OZAREK-HANC A, ZACZENIUK M, et al. Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: randomized, placebo controlled trial.Pulm Pharmacol Ther. 2015 Apr;31:42-8. doi: 10.1016/j.pupt.2015.01.004. Epub 2015 Jan 30.
7、 赵军. 白三烯拮抗剂孟鲁斯特钠与舒利迭联合治疗在老年哮喘患者中的应用效果[J]. 中国医学工程,2013(11):53. 赵军. 白三烯拮抗剂孟鲁斯特钠与舒利迭联合治疗在老年哮喘患者中的应用效果[J]. 中国医学工程,2013(11):53.
8、 王艳军. 沙美特罗替卡松联合孟鲁斯特对哮喘患儿IL-4 INF-γ IgE EOS影响研究[J]. 河北医学,2015(6):881-884. 王艳军. 沙美特罗替卡松联合孟鲁斯特对哮喘患儿IL-4 INF-γ IgE EOS影响研究[J]. 河北医学,2015(6):881-884.
9、 DILEK F, OZKAYA E, KOCYIGIT AS, et al. Effect of Montelukast Monotherapy on Oxidative Stress Parameters and DNA Damage in Children with Asthma[J]. Int Arch Allergy Immunol, 2015,167(2):119-26. doi: 10.1159/000436967. Epub 2015 Aug 18. DILEK F, OZKAYA E, KOCYIGIT AS, et al. Effect of Montelukast Monotherapy on Oxidative Stress Parameters and DNA Damage in Children with Asthma[J]. Int Arch Allergy Immunol, 2015,167(2):119-26. doi: 10.1159/000436967. Epub 2015 Aug 18.
10、 DESAI D, GUPTA S, SIDDIQUI S, et al. Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma[J]. Respir Res,2013,14(1):17. DESAI D, GUPTA S, SIDDIQUI S, et al. Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma[J]. Respir Res,2013,14(1):17.
11、 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南[J]. 中华结核和呼吸杂志,2008,31(3):177－185. 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南[J]. 中华结核和呼吸杂志,2008,31(3):177－185.
12、 冼乐武,梁宗安,刘春涛.支气管哮喘大鼠单个核细胞Th1/Th2的变化及孟鲁司特的干预作用[J]. 中华结核和呼吸杂志,2003,26(5),312-313. 冼乐武,梁宗安,刘春涛.支气管哮喘大鼠单个核细胞Th1/Th2的变化及孟鲁司特的干预作用[J]. 中华结核和呼吸杂志,2003,26(5),312-313.
13、 姚金晶,陈宜涛. Th1/Th2平衡调节与疾病发生的研究进展[J]. 现代生物医学进展,2009(13):2597-2600. 姚金晶,陈宜涛. Th1/Th2平衡调节与疾病发生的研究进展[J]. 现代生物医学进展,2009(13):2597-2600.
